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ABSTRACT
Introduction The Consolidated Standards for Reporting
Trials (CONSORT) were published to standardize
reporting and improve the quality of clinical trials. The
objective of this study is to assess CONSORT adherence
in randomized clinical trials (RCT) of disease speciﬁc
clinical decision support (CDS).
Methods A systematic search was conducted of the
Medline, EMBASE, and Cochrane databases. RCTs on
CDS were assessed against CONSORT guidelines and
the Jadad score.
Result 32 of 3784 papers identiﬁed in the primary
search were included in the ﬁnal review. 181702
patients and 7315 physicians participated in the selected
trials. Most trials were performed in primary care (22),
including 897 general practitioner ofﬁces. RCTs
assessing CDS for asthma (4), diabetes (4), and
hyperlipidemia (3) were the most common. Thirteen CDS
systems (40%) were implemented in electronic medical
records, and 14 (43%) provided automatic alerts.
CONSORT and Jadad scores were generally low; the
mean CONSORT score was 30.75 (95% CI 27.0 to 34.5),
median score 32, range 21e38. Fourteen trials (43%) did
not clearly deﬁne the study objective, and 11 studies
(34%) did not include a sample size calculation. Outcome
measures were adequately identiﬁed and deﬁned in 23
(71%) trials; adverse events or side effects were not
reported in 20 trials (62%). Thirteen trials (40%) were of
superior quality according to the Jadad score ($3
points). Six trials (18%) reported on long-term
implementation of CDS.
Conclusion The overall quality of reporting RCTs was
low. There is a need to develop standards for reporting
RCTs in medical informatics.
INTRODUCTION
Randomized controlled trials (RCTs) are considered
the gold standard for investigating the results of
clinical research because they inherently correct for
unknown confounders and minimize investigator
bias.
1e3 The results of these trials can have
profound and immediate effects on patient care.
When RCTs are reported, it is recommended that
the Consolidated Standards of Reporting Trials
(CONSORT)
4 are followed. CONSORT was ﬁrst
published in 1996 and has been revised several
times since.
5 The CONSORT statement is widely
supported and has been translated into several
languages to facilitate awareness and dissemina-
tion. An extension of the CONSORT statement
was published in 2008, focusing on randomized
trials in non-pharmacologic treatment.
6
CONSORTconsists of a checklist of information to
include when reporting on an RCT; however,
inadequate reporting remains common among
clinicians.
6e12 Higher quality reports are likely to
improve RCT interpretation, minimize biased
conclusions, and facilitate decision making in light
of treatment effectiveness.
1 Furthermore, there is
evidence that studies of lower methodological
quality tend to report larger treatment effects than
high quality studies.
13e15
Research on clinical decision support (CDS) tools
has rapidly evolved in the last decade. CDS provides
clinicians with patient speciﬁc assessment or
guidelines to aid clinical decision making
16 and
improve quality of care and patient outcome.
17 18
CDS has been shown to improve prescribing
practices,
19 reduce serious medication errors,
20 21
enhance delivery of preventive care services,
22 and
improve guidelines adherence,
23 and likely results
in lasting improvements in clinical practice.
24
However, clinical research on CDS tools faces
various methodological problems
25e28 and is
challenging to implement in the ﬁeld of health
informatics.
29 Guidelines for reporting studies in
health informatics have been published,
26 but there
is no universal consensus.
Numerous RCTs examining (disease speciﬁc) CDS
tools aimed at improving patient treatment have
been performed. It is unclear whether these studies
provided CONSORT statements when the trials
were reported. Although several studies have eval-
uated the quality of RCTs in medical journals,
3 78to
date none have been directed at medical informatics
literature published in dedicated journals. The
objective of this paper is to perform a systematic
review of RCTs to assess the quality of clinical CDS
research focusing on disease speciﬁc interventions.
We aimed to score the identiﬁed RCTs according to
the CONSORT
6 checklist and Jadad score.
3 Finally,
we discuss the implications of these results in the
context of evidence-based medicine.
MATERIALS AND METHODS
The review followed the PRISMA statements
(Preferred Reporting Items for Systematic Reviews
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Reviewand Meta-Analyses)
30 and was divided into two work phases: (a)
identiﬁcation of RCT trials assessing disease speciﬁc CDS and
(b) data extraction and assessment of RCT quality.
The Study Group of Research Quality in Medical Informatics
and Decision Support (SQUID) is a multidisciplinary study
group. Members have expertise in hospital medicine (KL, ROL,
KMA), RCTs in medicine (surgery) (KL),
31 RCTs in telemedicine
(RW),
32 trials of medical informatics (JGB, KMA),
33e37 and
epidemiological research (GB).
38e41 The group’s objective is to
assess and improve the quality of clinical informatics research
with special focus on randomized controlled trails aimed at
enhancing physician performance.
We deﬁned CDS as ‘any electronic or non-electronic system
designed to aid directly in clinical decision making, in which
characteristics of individual patients are used to generate
patient speciﬁc assessments or recommendations that are
subsequently presented to clinicians for consideration.’
42 We
deﬁned disease speciﬁc CDS as ‘a clinical decision support aimed
at a speciﬁc disease, describing symptoms, diagnosis, treatment,
and follow-up.’
Search strategy
This systematic review is based on a PubMed, EMBASE, and
Cochrane Controlled Trials Register search using EndNote X3
(EndNote, San Francisco, California, USA) for relevant publica-
tions published through November 2010. We piloted search
strategies and modiﬁed them to ensure they identiﬁed known
eligible articles. We combined keywords and/or subject headings
to identify CDS (clinical decision support system, computer-assisted
decision making, computer-assisted diagnosis, hospital information
systems) in the area of RCTs (ie, randomized controlled trial). We
searched publications accessible from the web pages of the
International Journal of Medical Informatics, Journal of the American
Medical Informatics Association, and BMC Medical Informatics and
Decision Making. We systematically searched the reference lists of
included studies. Reviews addressing CDS were investigated and
papers fulﬁlling the inclusion criteria were included.
17 42e44 The
searches were individually tailored for each database or journal.
Experienced clinicians reviewed all search hits and decided
whether a CDS was aimed at a speciﬁc disease and fulﬁlled
inclusion criteria. The titles, index terms, and abstracts of the
identiﬁed references were studied and each paper was rated as
‘potentially relevant’ or ‘not relevant.’ Disagreements regarding
inclusion were resolved by discussion. Only trials performed the
last 10 years were included.
Inclusion criteria were:
< Randomized controlled trial
< CDS describing speciﬁc diseases and treatment guidelines
< CDS aimed at physicians.
Exclusion criteria were:
< Papers published before the year 2000
< Not published in English
< Proceedings, symposium, and protocol papers.
The search strategy yielded 3784 papers. We retrieved and
reviewed the full text of 364 papers; 32 papers
45e76 were
included in the ﬁnal review (ﬁgure 1).
Assessing RCT quality
Scoring according to CONSORT
A checklist of 22 items from the revised 2001 CONSORT
guidelines was analyzed.
4e6 The score for each item ranged from
0t o2( 0 ¼no description, 1¼inadequate description, 2¼adequate
description). The maximum score a paper could obtain was
44 points.
Each article was then assessed for every item on the checklist
and scored independently by two observers (KMA and GB). The
scores for the 22 items were added together and a percentage
score for each trial was calculated.
Scoring according to Jadad
The Jadad scale is a 5-point scale for evaluating the quality of
randomized trials in which three points or more indicates
superior quality.
3 The Jadad scale is commonly used to evaluate
RCT quality.
78The scale contains two questions each for
randomization and masking, and one question evaluating
reporting of withdrawals and dropouts.
Scoring according to the sequential phases of a complex intervention
An RCT evaluating a CDS tool is deﬁned as a complex inter-
vention, that is an intervention consisting of various inter-
connecting parts.
29 77e79 Cambell et al
77 suggested four
sequential phases for developing RCTs for complex interven-
tions: theory, modeling, exploratory trial, deﬁnitive randomized
controlled trial, and long-term implementation. Included trials were
scored according to these sequential phases, that is one point
was given for each phase.
Scoring according to CDS features critical for success
Kawamoto et al identiﬁed certain CDS factors associated with
clinical improvement.
42 These factors are: automatic provision of
CDS, CDS at the time and location of decision making, provision of
a recommendation rather than just an assessment, computer based
assessment, and automatic provision of decision as part of clinician
workﬂow. The identiﬁed CDS tools were scored according to
these factors, giving one point for each feature.
All appraised papers were discussed by the two reviewers and,
if necessary, by a third independent reviewer to verify the
Figure 1 Selection process of randomized controlled trials of disease
speciﬁc clinical decision support.
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Reviewappraisal process and resolve disagreement; when consensus
could not be reached, the third reviewer assessed the items and
provided the tiebreaker score.
Statistics
Trial characteristics and CONSORTadherence were analyzed and
interpreted with the trial as unit of analysis. Descriptive statistics
were analyzed using percentages, standard deviation, conﬁdence
intervals, 232 contingency tables, c
2 test, and Fisher’s exact test
when appropriate. We used proportions for categorical variables
and mean for continuous variables. For reasons of comparison,
trials were divided into groups according to whether or not their
outcome was positive. A positive outcome was deﬁned as either
a primary or secondary outcome with p<0.05. All tests were
two-sided and a probability (p) value of <0.05 was considered
statistically signiﬁcant. Microsoft Excel and SPSS PASW Statis-
tics v 18.0 were used for the statistical analyses.
RESULTS
Clinical features
Of 3784 potentially relevant articles screened, 32 papers met all
our inclusion criteria (table 1).
Fourteen (43%) of the trials were performed in the US, seven
(21%) in the Netherlands, and four (12%) in the UK. Four of the
trials were published in medical informatics journals, and the
rest in medical journals. The trials included 181702 patients and
7315 physicians. The majority (22 trials) were performed in
primary care, including 897 general practitioner (GP) ofﬁces. Of
the 11 trials performed at hospital level, two were performed in
an outpatient department, three in internal medicine depart-
ments, one in a surgical department, one in an intensive care
unit, two in emergency departments, one in a trauma unit, and
one in various different departments. Asthma (n¼4), diabetes
(n¼4), and hyperlipidemia (n¼3) were the most common
diseases addressed (table 1).
General trial features
Twenty-six trials (81%) did not provide an RCT registration
number (ie, http://Clinicaltrials.gov and others), while only
seven trials (21%) offered web access to the full trial protocol.
One trial did not state funding sources (table 2). In nine trials
(28%), more than half of the authors were medical doctors; in 10
trials, information on the background and education of the
author(s) was not provided. Twenty-two (68%) trials chose
a cluster-randomized design, which was the most common
design among trials in primary care (21 of 22). Of the nine trials
performed in a hospital setting, four had a cluster-randomized
design and in these cases the department was chosen as the
clustering unit. Two trials provided information on changes to
the trial protocol, and one trial addressed CONSORT guidelines.
CDS features
Less than half of the CDS tools were implemented in an elec-
tronic medical record, and 14 (43%) of the CDS tools provided
automatic alerts (table 2). Twenty-four (75%) of the developed
CDS tools provided decision support at the time and location of
the decision need. Eighteen (56%) of the CDS tools did not
disrupt the natural workﬂow of the physician. None of these
CDS features had a signiﬁcant inﬂuence upon the primary
endpoint or overall conclusions.
Addressing sequential phases of a complex intervention
None of the trials deﬁned the intervention as complex or
discussed the deﬁnition of a complex intervention.
77 78 80 Four
trials deﬁned all phases of a complex intervention and these
phases were described in detail (table 2).
Trials reporting on long-term CDS implementation
Six trials reported on the long-term implementation of the CDS
tool used in the RCT (table 1).
Four of these trials addressed all phases of a complex inter-
vention and had a statistically higher CONSORT score
compared to trials not reporting long-term implementation (OR
1.64, p¼0.04). Three of these trials were performed at a hospital
level, with the largest trial including 87000 patients.
Inter-rater reliability and CONSORT score
The intraclass correlation coefﬁcient used to establish inter-rater
reliability was 0.69 for the 22-item CONSORTscale. The mean
CONSORTscore was 30.75 (95% CI 27.0 to 34.5), median score
32, range 21e38.
CONSORT: title, abstract, and background
Five trials did not identify a randomized design in their title. All
trials had a structured abstract and gave a solid background and
rationale for the trial (table 3).
CONSORT: materials and methods
One trial addressed the CONSORT guidelines in their Material
and Methods section. Twenty-seven trials (84%) clearly deﬁned
their participants, eligibility, and ethics approval. Fourteen trials
(43%) did not clearly deﬁne the study objective or hypothesis.
Twenty-three trials (72%) had an adequate deﬁnition of outcome
measures. Fourteen studies (37%) did not perform or had an
inadequate sample size calculation (table 3).
CONSORT: randomization
Most trials described mechanisms to generate random allocation
(59%) and the method of implementing the random sequence
(47%). In contrast, only ﬁve trials (15%) gave adequate infor-
mation regarding blinding (whether or not blinding was neces-
sary and if necessary, how it was performed) (table 3).
CONSORT: results
Most trials (87%) provided a detailed description of statistical
methods (table 3). Five trials had no ﬁgure showing participant
ﬂow and four trials did not include a table showing demographics.
Nine trials did not address exclusions during the trial, and 10 trials
did not deﬁne the date of trial initiation and termination. Only
two trials performed an interim analysis, and only one trial
addressed the ‘harms or unintended effects’ of the intervention.
CONSORT: discussion
The interpretation of results was justiﬁed in 28 trials (87%). Four
trials did not discuss limitations and six trials did not address
generalizabilityorproviderecommendationsforthefuture(table3).
Jadad score
Thirteen trials (40%) were classiﬁed as superior quality trials ($3
points). Nineteen (59%) described the study as randomized, and
the sequence of randomization was explained and was appro-
priate. Twenty-seven (85%) did not describe blinding. Ten (32%)
did not describe dropouts (table 4).
DISCUSSION
Summary of ﬁndings
This is the ﬁrst review assessing the quality of RCTs of disease
speciﬁc CDS as a primary intervention. We have analyzed their
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Reviewoutcome, CONSORT adherence and Jadad score. Methodologi-
cally, research quality varies and adherence to CONSORT
guidelines is low for certain checklist items. Thirteen trials
(40%) were classiﬁed as superior quality trials according to their
Jadad score ($3 points). According to our analysis, there is
considerable room for improving methodology in areas such as
the description of speciﬁc research objectives, randomization
methods, sample size calculations, reporting of adverse events,
and a general focus on CONSORT. Similarly, the Jadad score was
low on several checklist items. Surprisingly few studies deﬁned
their CDS intervention as a complex intervention; only four
studies described all phases of a complex intervention including
long-term implementation.
Research challenges of complex interventions
A complex intervention was deﬁned by Cambell et al
77 81 as an
intervention that is ‘built up from a number of components,
which may act both independently and interdependently.’
Similarly, Campbell deﬁned an intervention with a decision
support system as a complex intervention.
77 In 2000, the
Medical Research Council in the UK proposed a framework for
the development and evaluation of RCTs for complex inter-
ventions (theory, modeling, exploratory trial, deﬁnitive RCT,
long-term implementation),
77 which was further improved in
2007.
81 The methodological challenges of complex interventions
have been thoroughly discussed in the ﬁeld of medical infor-
matics,
25 29 as well in the area of health service research.
79 82e85
There have been arguments against over-standardization of
complex interventions. Complex and large health organizations
are characterized by ﬂux, contextual variation, and adaptive
learning rather than stability, and a standardized approach will
not ﬁt such organizations.
86 However, our review shows that
most trials do not address the term ‘complex intervention’ and
as many as 23 trials (71%) did not perform an exploratory trial
before the deﬁnitive RCT. This problem is well discussed by
Friedman, who introduces the ‘tower of achievements.’
87
According to Friedman, integration across research phases is of
utmost importance to success in the ﬁeld.
Quality of RCTs in medical informatics versus clinical trials
Our survey shows generally low CONSORTadherence and only
13 trials were deﬁned as superior quality trials according to their
Jadad score. However, the research quality of RCTs has been of
varying quality in medical research as well. In a review from
2006
8 assessing 69 RCTs of surgery, only 37% of trials were
classiﬁed as of superior quality. CONSORTscores were generally
low but signiﬁcantly higher in trials with higher author
numbers, multi-centre trials, and trials with a declared funding
source.
8 It has been concluded that there is a need to improve
awareness of the CONSORT statement among authors,
reviewers, and editors.
8 Similar concerns were recently reported
in several medical journals, which concluded that there was low
adherence to key methodological items.
88e90 These conclusions
from the medical literature are in accordance with our review
ﬁndings.
Strength and limitations of our study
This study has several important strengths. First, our literature
search was thorough and we screened more than 3700 articles.
Second, this is the ﬁrst review to evaluate the general trial
quality and CONSORTadherence of RCTs evaluating CDS tools
as a clinical intervention. Research on CDS tools is methodo-
logically challenging.
28 Thus, a focus on research methods in
medical informatics is important, and adherence to CONSORT
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Reviewhas never been assessed. Third, we are currently recruiting
patients into an RCTaddressing the use of disease speciﬁc CDS
tools
37 and thus have experienced the inherent methodological
challenges. In addition to technological problems, these trials
also face the challenges of a complex intervention. These
research questions have been addressed in this review.
One limitation of our study might be that only RCTs
assessing CDS systems aimed at physicians were included.
However, when planning this review, the research group wanted
to identify CDS trials to improve patient treatment as these
trials should ideally adhere to research conventions in general
medical society. In this context the research group felt it natural
to exclude CDS not addressing physicians.
Another limitation might be the reporting of the various
phases in a complex intervention. Our review shows that only
six trials (18%) report on long-term implementation. However,
all studies were RCTs and thus were in the stage prior to
implementation. It may be that implementation did occur after
the RCTwas published but was not part of the publication. It
might also be that some providers implemented their long-term
intervention, but as the RCT did not support this, they were
reluctant to report on it. Similarly, it is possible that theoretical
and preliminary work might have been carried out but was not
fully described in an RCT paper.
Finally, it is unclear whether or not ‘complex intervention’ is
a term widely accepted in medical informatics circles. We iden-
tiﬁed the term ‘complex intervention’ in one JAMIA article from
2008, with the other mentions of this concept all being in BMJ.
Since JAMIA readership is largely within the US, it is unclear
whether it is mandatory for CDS and their evaluation to be
declared as complex interventions and thus follow the required
phases.
Table 3 The CONSORT checklist: scoring of 32 RCT trials of disease speciﬁc clinical decision support systems
Item* Description No description, n (%) Inadequate, n (%) Adequate, n (%)
1 Allocation (eg, ‘random allocation,’ ‘randomly assigned,’ or ‘randomized’) 0 5 (15.6) 27 (84.4)
2 Justiﬁcation 0 3 (9.4) 29 (90.6)
3 Eligibility criteria for participants and location of data collection 2 (6.3) 3 (9.4) 27 (84.4)
4 Details and timing of interventions 8 (25.0) 2 (6.3) 22 (68.8)
5 Speciﬁc objectives and hypotheses 3 (9.4) 11 (34.4) 18 (56.3)
6 Identiﬁcation and deﬁnition of outcome measures 4 (12.5) 5 (15.6) 23 (71.9)
7 Prestudy sample size calculation 11 (34.4) 3 (9.4) 18 (56.3)
8 Method of generation of the random sequence 5 (15.6) 8 (25.0) 19 (59.4)
9 Method of implementation of the random sequence 10 (31.3) 7 (21.9) 15 (46.9)
10 Details of personnel involved in recruitment, allocation, and
outcome measurement
14 (43.8) 7 (21.9) 11 (34.4)
11 Whether subjects, treatment providers, or assessors/analysts were blinded 24 (75.0) 3 (9.4) 5 (15.6)
12 Statistical methods 0 4 (12.5) 28 (87.5)
13 Flow of participants through each stage 5 (15.6) 2 (6.3) 25 (78.1)
14 Dates deﬁning the periods of recruitment and follow-up 9 (28.1) 1 (3.1) 22 (68.8)
15 Baseline demographic and clinical characteristics of each group 4 (12.5) 0 28 (87.5)
16 Number of participants in each group analysis; whether the analysis was by
‘intention to treat’
1 (3.1) 16 (50.0) 15 (46.9)
17 Complete reporting of results with CIs 2 (6.3) 12 (37.5) 18 (56.3)
18 Multiple testing and corrections 0 0 0
19 All important adverse events or side effects 20 (62.5) 11 (34.4) 1 (3.1)
20 Interpretation of the results, including trial limitations and weaknesses 1 (3.1) 3 (9.4) 28 (87.5)
21 Generalizability (external validity) of the trial ﬁndings 1 (3.1) 5 (15.6) 26 (81.3)
22 General interpretation of the results in the context of current evidence 0 1 (3.1) 31 (96.9)
The mean CONSORT score for the 32 included trials was 30.75 (95% CI 27.0 to 34.5), median score 32, range 21e38. The intraclass correlation coefﬁcient used to establish inter-rater reliability
was 0.69. All appraised papers were discussed by the two reviewers and, if necessary, by a third independent reviewer to verify the appraisal process and resolve disagreement; when
consensus could not be reached, the third reviewer assessed the items and provided the tiebreaker score.
*Score for each item: 0¼no description, 1¼inadequate description, 2¼adequate description; maximum score¼44.
RCT, randomized controlled trial.
Table 2 Characteristics of RCTs of clinical decision support and impact
on outcome and implementation
Outcome +,
n[24 (%)
Outcome L,
n[8 (%)
Total,
n[32 (%)
General trial features
Protocol access 7 (29) 0 7 (21)
Identiﬁcation of RCT number 6 (25) 0 6 (18)
Funding sources identiﬁed 23 (95) 8 (100) 31 (96)
>50% MD authors 8 (33) 1 (12) 9 (28)
Primary care 17 (70) 5 (62) 22 (68)
Clustered design 18 (75) 4 (50) 22 (68)
Patients 158240 23462 181702
Participating MDs 2270 846 3116
CDS feature
CDS time/location of decision 17 (70) 7 (87) 24 (75)
Automatic alert 11 (45) 3 (37) 14 (43)
Implemented in EMR 10 (41) 3 (37) 13 (40)
No disruption to workﬂow 15 (62) 3 (37) 18 (56)
All features present 8 (33) 0 8 (25)
Phases of complex interventions
Theory 24 (100) 8 (100) 32 (100)
Modeling 8 (33) 5 (62) 13 (40)
Exploratory trial 7 (29) 2 (25) 9 (28)
Deﬁnitive RCT 24 (100) 8 (100) 32 (100)
Long-term implementation 4 (16) 2 (25) 6 (18)
All phases present 3 (12) 1 (12) 4 (12)
RCT assessment tool
CONSORT score mean (SD) 29.9 (4.7) 33.1 (3.9) 30.7 (4.7)
Jadad score mean (SD) 2.0 (1.5) 2.75 (1.6) 2.2 (1.5)
Outcome + is deﬁned as either a positive primary or positive secondary endpoint (p<0.05).
There were no signiﬁcant differences between Outcome + and Outcome  .
CDS, clinical decision support; EMR, electronic medical record; MDs, medical doctors,
including hospital physicians and general practitioners; RCT, randomized controlled trial.
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Recently, Liu
28 discussed the pros and cons of RCTs in medical
informatics. We agree with their view that RCTs are not the
only method for evaluation. Medical informatics interventions
are usually performed in a complex organizational environment.
In this context, there is a need for different research methods,
and often a mixture of qualitative and quantitative methods,
depending on the research subject. However, when an RCT is
deemed the proper design, standards of reporting must be
followed. In addition, RCTs in medical informatics face several
methodological challenges, some of which have been clariﬁed in
this review.
Choice of outcome measures
In principal, outcomes can either be patient orientated, process
orientated, or system orientated. The choice of outcome
measures should be clearly related to the research question. Our
review shows a large mixture of primary outcomes, which
makes meta-analyses of effects impossible. Thus, a clear
conclusion regarding the effects of CDS (in the form of
a meta-analyses) cannot be reached.
Sample size calculations
The planning of an RCT should begin with sample size calcu-
lation. This assessment is closely related to the choice of primary
outcome, as different primary outcomes can result in different
sample size estimates. The sample estimate is crucial to deter-
mine the resources and time needed to conduct a properly
designed RCT with enough power to reject or accept the null
hypothesis. Kiehan et al
7 address concerns about the poor
standards of reporting sample size calculations. They conclude
that many of these trials are ﬂawed from the start due to
inadequate power to assess any real difference between inter-
ventions. In this review, approximately 50% of the trials had an
inadequate estimate of sample size, a surprisingly low number.
Randomization
Should randomization be performed at an individual or an
organizational level? In this review, 68% preferred a clustered
design, clustered at the level of hospitals, departments, or GP
ofﬁces. There are obvious advantages to a cluster design in
complex health organizations, as problems of blinding and
random sequence implementation will be avoided. In addition,
clustering randomization is usually less demanding of resources,
as randomization can be performed before the actual trial period
with fewer personnel involved.
Conclusion
The research methodology in the identiﬁed trials is of low
quality, suggesting a need for increased focus on the methods of
conducting and reporting RCT trials. Study designs that adhere
to CONSORTare not always appropriate in medical informatics
research.
26 However, RCTs evaluating CDS tools in a clinical
setting should adjust to the accepted consensus. Thus,
CONSORT guidelines for conducting RCT trials should be
addressed and subsequently implemented in the trial.
CONSORT guidelines for non-pharmacological treatment
6
provide a solid basis for reporting RCTs evaluating CDS systems,
but an adjustment for medical informatics is needed. The soci-
eties for medical informatics should aim for a consensus state-
ment to improve the quality of reporting RCTs, trials of
informatics applications, and CDS.
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